Article History
Received: 12 August 2020
First Online: 29 September 2020
Compliance with ethical standards
:
: Hiroshi Ikegami is the Chairman of the Committee on Type 1 Diabetes, Japan Diabetes Society. Akihisa Imagawa and Akira Shimada are Vice-chairmen of the Committee on Type 1 Diabetes, Japan Diabetes Society. A.S. has received lecture fees from Astellas Pharm Inc., Eli Lilly Japan K.K., Ono pharmaceutical Co., Ltd., Terumo Corporation and Sanofi K.K. A.S. has received research funding from Astellas Pharm inc. and Mitsubishi Tanabe Pharma Corporation. A.S. has received scholarship grants from Astellas Pharm inc., Daiichi Sankyo Co., Ltd. and Kyowa Kirin Co., Ltd., MSD K.K., Novo Nordisk Pharma Ltd. and Ono Pharmaceutical Co., LTD. The other authors declare that they have no financial conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.